A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients

BACKGROUND: Pterygium is an ocular surface disorder with prevalence rates ranges from 0.3% to 29% in different parts of the world. Vascular endothelial growth factor (VEGF) has been detected in increased amounts in pterygium epithelium, compared with normal conjunctiva. Bevacizumab is a recombinant,...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Priyanka, Sarkar, Lopa, Sethi, H S, Gupta, V S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728977/
https://www.ncbi.nlm.nih.gov/pubmed/26655003
http://dx.doi.org/10.4103/0301-4738.171508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728977/
https://www.ncbi.nlm.nih.gov/pubmed/26655003
http://dx.doi.org/10.4103/0301-4738.171508

Ejemplares similares